\-\ Texto\\:\\ \ \(0\)\
\-\ age\\ 36\\:\\ colour\\ blindness\\ for\\ blue\\ and\\ yellow\\.\ \(0\)\
\-\ age\\ 43\\:\\ vod\\ 0\\.6\\,\\ vos\\:\\ 0\\.6\\;\\ central\\ scotoma\\,\\ temp\\ of\\ optic\\ nerve\\:\\ atrophy\\.\\ red\\ foveae\\.\\ \\â\\€\\œretinitis\\ pigmentosa\\â\\€\\\\;\\ \ \(0\)\
\-\ erg\\:\\ reduced\\ photopic\\ reaction\\,\\ normal\\ scotopic\\ reaction\\.\\ \ \(0\)\
\-\ dark\\ adaptation\\,\\ eog\\ and\\ vep\\:\\ normal\\ \ \(0\)\
\-\ age\\ 44\\:\\ vod\\ 0\\.4\\,\\ vos\\:\\ 0\\.4\\	\\	\ \(0\)\
\-\ age\\ 46\\:\\ vod\\ 0\\.2\\,\\ vos\\:\\ 0\\.3\\;\\ bull\\â\\€\\™s\\ eye\\ maculopathy\ \(0\)\
\-\ age\\ 49\\:\\ vod\\ 0\\.1\\ \\ vos\\:\\ 0\\.16\\;\\ central\\ field\\ defect\\,\\ macular\\ pigmentary\\ changes\\ \\-\\>\\ loss\\ peripheral\\ vision\\.\ \(0\)\
\-\ age\\ 57\\:\\ cause\\ of\\ death\\:\\ aspiration\\ pneumonia\ \(0\)\
\-\ duration\\ disease\\:\\ 24\\ years\ \(0\)\
\-\ pm\\ delay\\:\\ 38\\ h\ \(0\)\
\-\ age\\:\\ 45\\:\\ clinical\\:\\ adca\\ ii\\ \\:\\ non\\-pure\\ cerebellar\\ ataxia\\ \\ with\\ visual\\ disturbance\ \(0\)\
\-\ age\\ 50\\:\\ \\ dna\\:\\ mutation\\ analysis\\:\\ sca7\\ \\(\\=adca\\ ii\\)\\:\\ cag\\ \\ 42\\ repeats\ \(0\)\
\-\ spino\\-cerebellar\\ ataxia\ \(0\)\
\-\ male\\,\\ age\\ 33\\:\\ onset\\ ataxia\\ \\ \ \(0\)\
\-\ age\\ 36\\:\\ onset\\ visual\\ disturbance\ \(0\)\
\-\ age\\ 45\\:\\ diagnosis\\:\\ adca\\ ii\ \(0\)\
\-\ age\\ 48\\:\\ wheelchair\\;\\ full\\ \\(transfers\\)\\ dependence\\ at\\ age\\ 56\\,\\ impaired\\ swallowing\ \(0\)\
\-\ family\\ history\\:\\ \ \(0\)\
\-\ m\\ \\+\\:\\ \ \(0\)\
\-\ \\ \\-\\ age\\ 50\\:\\ ataxia\\,\\ macular\\ degeneration\ \(1\)\
\-\ \\ \\-\\ age\\ 70\\:\\ \\â\\€\\˜severe\\ restricted\\ vision\\â\\€\\™\ \(1\)\
\-\ \\ \\-\\ age\\ 80\\ \ \(1\)\
\-\ mm\\:\\?\\+\\ died\\ at\\ early\\ age\ \(0\)\
\-\ sister\\ \\-\\;\\ father\\,\\ half\\-brother\\:\\ \\-\ \(0\)\
\-\ m\\:\\ 4\\ sisters\\-\\,\\ 1\\ brother\\:\\ \\-\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ age\\:\\ 0\\.1827085765878232\ \(0\)\
\-\ \\:\\:\\ 0\\.1728106123622091\ \(0\)\
\-\ vod\\:\\ 0\\.1342540701389513\ \(0\)\
\-\ vos\\:\\ 0\\.1342540701389513\ \(0\)\
\-\ ataxia\\:\\ 0\\.07548798647796924\ \(0\)\
\-\ adca\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ macular\\:\\ 0\\.05677362210670401\ \(0\)\
\-\ \\-\\:\\ 0\\.05298388103701878\ \(0\)\
\-\ disturbance\\:\\ 0\\.05047494399061395\ \(0\)\
\-\ \\;\\:\\ 0\\.050217054259155215\ \(0\)\
\-\ 0\\.6\\:\\ 0\\.048968154265044084\ \(0\)\
\-\ 0\\.4\\:\\ 0\\.04730971876535688\ \(0\)\
\-\ ii\\:\\ 0\\.04568950052533172\ \(0\)\
\-\ m\\:\\ 0\\.03643635683224996\ \(0\)\
\-\ \\+\\:\\ 0\\.03643635683224996\ \(0\)\
\-\ foveae\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ erg\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ photopic\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ scotopic\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ eog\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ vep\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ non\\-pure\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ transfers\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ half\\-brother\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ sisters\\-\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ 36\\:\\ 0\\.035396024221597044\ \(0\)\
\-\ pigmentosa\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ adaptation\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ maculopathy\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ pigmentary\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ sca7\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ \\=adca\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ cag\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ spino\\-cerebellar\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ dependence\\:\\ 0\\.033563517534737825\ \(0\)\
\-\ vision\\:\\ 0\\.032627966723230706\ \(0\)\
\-\ 45\\:\\ 0\\.032627966723230706\ \(0\)\
\-\ reaction\\:\\ 0\\.03207474785814716\ \(0\)\
\-\ visual\\:\\ 0\\.032015504143447886\ \(0\)\
\-\ colour\\:\\ 0\\.0318880418813983\ \(0\)\
\-\ bull\\:\\ 0\\.0318880418813983\ \(0\)\
\-\ repeats\\:\\ 0\\.0318880418813983\ \(0\)\
\-\ scotoma\\:\\ 0\\.030699272986969454\ \(0\)\
\-\ retinitis\\:\\ 0\\.030699272986969454\ \(0\)\
\-\ 0\\.16\\:\\ 0\\.029777192196414868\ \(0\)\
\-\ wheelchair\\:\\ 0\\.028386811053352005\ \(0\)\
\-\ dna\\:\\ 0\\.027835028439201083\ \(0\)\
\-\ \\â\\€\\˜\\:\\ 0\\.026912947648646497\ \(0\)\
\-\ 50\\:\\ 0\\.026867752203667807\ \(0\)\
\-\ 0\\.3\\:\\ 0\\.025828797795475048\ \(0\)\
\-\ 0\\.1\\:\\ 0\\.025828797795475048\ \(0\)\
\-\ brother\\:\\ 0\\.025522566505583634\ \(0\)\
\-\ blindness\\:\\ 0\\.025237471995306977\ \(0\)\
\-\ pm\\:\\ 0\\.024970783891432716\ \(0\)\
\-\ sister\\:\\ 0\\.024484077132522042\ \(0\)\
\-\ 0\\.2\\:\\ 0\\.02365485938267844\ \(0\)\
\-\ blue\\:\\ 0\\.02329530823809319\ \(0\)\
\-\ central\\:\\ 0\\.023236622783966605\ \(0\)\
\-\ yellow\\:\\ 0\\.022808601479182518\ \(0\)\
\-\ impaired\\:\\ 0\\.022808601479182518\ \(0\)\
\-\ mutation\\:\\ 0\\.022513316504049686\ \(0\)\
\-\ onset\\:\\ 0\\.022292737404340082\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.02110765900533435\ \(0\)\
\-\ father\\:\\ 0\\.02108242296389335\ \(0\)\
\-\ died\\:\\ 0\\.020697751794199085\ \(0\)\
\-\ swallowing\\:\\ 0\\.019868534044355485\ \(0\)\
\-\ temp\\:\\ 0\\.019578433801904046\ \(0\)\
\-\ 49\\:\\ 0\\.019578433801904046\ \(0\)\
\-\ dark\\:\\ 0\\.019307370651136222\ \(0\)\
\-\ 57\\:\\ 0\\.019242294795895974\ \(0\)\
\-\ 43\\:\\ 0\\.019052999192460878\ \(0\)\
\-\ death\\:\\ 0\\.019052999192460878\ \(0\)\
\-\ 38\\:\\ 0\\.018813382425310672\ \(0\)\
\-\ 46\\:\\ 0\\.018698590838091354\ \(0\)\
\-\ duration\\:\\ 0\\.018698590838091354\ \(0\)\
\-\ reduced\\:\\ 0\\.018586902109215653\ \(0\)\
\-\ h\\:\\ 0\\.018586902109215653\ \(0\)\
\-\ 56\\:\\ 0\\.018586902109215653\ \(0\)\
\-\ red\\:\\ 0\\.01842483304659879\ \(0\)\
\-\ 33\\:\\ 0\\.01832021400534139\ \(0\)\
\-\ atrophy\\:\\ 0\\.01821817841612498\ \(0\)\
\-\ 44\\:\\ 0\\.018118601756707372\ \(0\)\
\-\ field\\:\\ 0\\.018118601756707372\ \(0\)\
\-\ analysis\\:\\ 0\\.017973596302941798\ \(0\)\
\-\ degeneration\\:\\ 0\\.0179263702871417\ \(0\)\
\-\ 42\\:\\ 0\\.017879677910059334\ \(0\)\
\-\ delay\\:\\ 0\\.017523997708525273\ \(0\)\
\-\ 48\\:\\ 0\\.017275989403871334\ \(0\)\
\-\ 70\\:\\ 0\\.016966893482042004\ \(0\)\
\-\ aspiration\\:\\ 0\\.01664473835200187\ \(0\)\
\-\ 80\\:\\ 0\\.016610445778387425\ \(0\)\
\-\ optic\\:\\ 0\\.016345892642995147\ \(0\)\
\-\ restricted\\:\\ 0\\.01625089463380218\ \(0\)\
\-\ full\\:\\ 0\\.015254357208939005\ \(0\)\
\-\ cerebellar\\:\\ 0\\.015229833508443905\ \(0\)\
\-\ eye\\:\\ 0\\.014811610773189716\ \(0\)\
\-\ pneumonia\\:\\ 0\\.014596341715820289\ \(0\)\
\-\ family\\:\\ 0\\.014472365474895499\ \(0\)\
\-\ \\?\\:\\ 0\\.013780493804233499\ \(0\)\
\-\ 24\\:\\ 0\\.013729161076966735\ \(0\)\
\-\ \\,\\:\\ 0\\.013423639612427474\ \(0\)\
\-\ defect\\:\\ 0\\.013217964158264161\ \(0\)\
\-\ \\â\\€\\œ\\:\\ 0\\.013188020321401487\ \(0\)\
\-\ \\â\\€\\\\:\\ 0\\.013114096500117292\ \(0\)\
\-\ mm\\:\\ 0\\.012984277507417378\ \(0\)\
\-\ early\\:\\ 0\\.012913880039844785\ \(0\)\
\-\ peripheral\\:\\ 0\\.012776583975264948\ \(0\)\
\-\ nerve\\:\\ 0\\.01272291787804672\ \(0\)\
\-\ cause\\:\\ 0\\.011947366225421347\ \(0\)\
\-\ \\>\\:\\ 0\\.01173209716805192\ \(0\)\
\-\ normal\\:\\ 0\\.011071177310736372\ \(0\)\
\-\ clinical\\:\\ 0\\.010864916529198364\ \(0\)\
\-\ severe\\:\\ 0\\.010864916529198364\ \(0\)\
\-\ years\\:\\ 0\\.010368773293464804\ \(0\)\
\-\ loss\\:\\ 0\\.010249851952348924\ \(0\)\
\-\ s\\:\\ 0\\.010127139120308212\ \(0\)\
\-\ changes\\:\\ 0\\.01012003295964901\ \(0\)\
\-\ 4\\:\\ 0\\.009838726880905146\ \(0\)\
\-\ at\\:\\ 0\\.009568290519269695\ \(0\)\
\-\ 1\\:\\ 0\\.008402175074213664\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008108344342067851\ \(0\)\
\-\ male\\:\\ 0\\.006385146850774683\ \(0\)\
\-\ \\(\\:\\ 0\\.005969931621850087\ \(0\)\
\-\ \\)\\:\\ 0\\.00589700571994467\ \(0\)\
\-\ disease\\:\\ 0\\.005771642732296299\ \(0\)\
\-\ history\\:\\ 0\\.004876919577301997\ \(0\)\
\-\ for\\:\\ 0\\.0030128435894327074\ \(0\)\
\-\ and\\:\\ 0\\.0014876777333241195\ \(0\)\
\-\ of\\:\\ 0\\.0009628413289089953\ \(0\)\
\-\ \\.\\:\\ 0\\.0007334614896145925\ \(0\)\
\-\ with\\:\\ 0\\.0004834883309499576\ \(0\)\
